Literature DB >> 19444398

[Vitiligo. Diagnosis, differential diagnosis, and current patient management].

A Hartmann1.   

Abstract

Vitiligo is characterized by patches of depigmented skin in a localized to generalized distribution. Up to now, vitiligo is not curable and mostly has a chronic and progressive course. The disorder may be part of a polygenic, multifactorial transmitted disease with an increased disposition to autoimmune disorders, which should be screened for. Depending on the age of the patient, the psychological strain, the location, the body surface area involved, and the disease activity, several conservative as well as surgical therapeutic options may be partially successful. How long the induced repigmentation remains and the effect of the available therapeutic options on the natural history of vitiligo remain to be clarified.

Entities:  

Mesh:

Year:  2009        PMID: 19444398     DOI: 10.1007/s00105-009-1770-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  23 in total

1.  The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force.

Authors:  Alain Taïeb; Mauro Picardo
Journal:  Pigment Cell Res       Date:  2007-02

2.  Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study.

Authors:  Anke Hartmann; Eva-Bettina Bröcker; Henning Hamm
Journal:  Acta Derm Venereol       Date:  2008       Impact factor: 4.437

3.  Repigmentation of skin and hairs in stable vitiligo by transplantation of autologous melanocytes in fibrin suspension.

Authors:  A Hartmann; E B Broecker; H Hamm
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-05       Impact factor: 6.166

4.  Audiological abnormalities in patients with vitiligo.

Authors:  K Aydogan; O F Turan; S Onart; S K Karadogan; S Tunali
Journal:  Clin Exp Dermatol       Date:  2006-01       Impact factor: 3.470

5.  Segmental vitiligo: clinical findings in 208 patients.

Authors:  S K Hann; H J Lee
Journal:  J Am Acad Dermatol       Date:  1996-11       Impact factor: 11.527

6.  Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study.

Authors:  D C Patel; A V Evans; J L M Hawk
Journal:  Clin Exp Dermatol       Date:  2002-11       Impact factor: 3.470

7.  Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.

Authors:  Anke Hartmann; Christa Lurz; Henning Hamm; Eva-B Bröcker; Uta B Hofmann
Journal:  Int J Dermatol       Date:  2005-09       Impact factor: 2.736

8.  CD4 T cell-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions.

Authors:  Teresa Lambe; Janson C H Leung; Tiphaine Bouriez-Jones; Karlee Silver; Kimmo Makinen; Tanya L Crockford; Helen Ferry; John V Forrester; Richard J Cornall
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

9.  Surgical combination therapy for vitiligo and piebaldism.

Authors:  R Falabella; M Barona; C Escobar; I Borrero; A Arrunategui
Journal:  Dermatol Surg       Date:  1995-10       Impact factor: 3.398

10.  Vitiligo and melanoma-associated hypopigmentation (MAH): shared and discriminative features.

Authors:  Anke Hartmann; Christina Bedenk; Petra Keikavoussi; Jürgen C Becker; Henning Hamm; Eva-Bettina Bröcker
Journal:  J Dtsch Dermatol Ges       Date:  2008-05-07       Impact factor: 5.584

View more
  3 in total

1.  [Methods and means for pigmentation and depigmentation. Sense or nonsense?].

Authors:  V Hegyi; J Hegyi
Journal:  Hautarzt       Date:  2010-07       Impact factor: 0.751

2.  [Association between allergy to benzoyl peroxide, vitiligo and implantation of a cemented total knee joint prosthesis: Is there a connection?].

Authors:  M Gothner; L Ozokyay; P Godau; T Kälicke; G Muhr; T A Schildhauer; M Dudda
Journal:  Orthopade       Date:  2011-09       Impact factor: 1.087

3.  [Prevalence of an association between coeliac disease and vitiligo].

Authors:  J Henker; A Hartmann
Journal:  Hautarzt       Date:  2019-12       Impact factor: 0.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.